JNJ-7706621

SKU: orb1301051

Description

JNJ-7706621 is a dual-action small molecule inhibitor targeting aurora kinases as well as CDK1 and CDK2. It is utilized in cancer research to study cell cycle progression and mitotic events, demonstrating activity in both cellular assays and in vivo tumor models.

Research Area

Cell Biology, Epigenetics & Chromatin

Key Properties

• CAS Number: 443797-96-4
• MW: 394.36
• Purity: 99.85% (May vary between batches)
• Formula: C₁₅H₁₂F₂N₆O₃S
• SMILES: Nc1nc(Nc2ccc(cc2)S(N)(=O)=O)nn1C(=O)c1c(F)cccc1F
• Target: CDK,Aurora Kinase,Apoptosis
• Solubility: DMSO:55 mg/mL (139.47 mM);H2O:< 1 mg/mL (insoluble or slightly soluble);10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (5.07 mM);Ethanol:< 1 mg/mL (insoluble or slightly soluble)

Bioactivity

• Target IC50:
  Aurora B:15 nM|Cdk4-CyclinD1:253 nM|Aurora A:11 nM|FGFR1:575 nM|CDK2-CyclinE:3 nM|CDK6-CyclinD1:175 nM|CDK3-CyclinE:58 nM|CDK2-CyclinA:4 nM|VEGFR1:6400 nM|FGFR2:226 nM|CDK1-CyclinB:9 nM|VEGFR3:735 nM|VEGFR2:154 nM|GSK-3β:254 nM
  Read more...
• In Vivo:
  JNJ-7706621 demonstrates varied potency across different cell types, exhibiting greater effectiveness in inhibiting the growth of normal cell types, including MRC-5, HASMC, HUVEC, and HMVEC, with IC50 values ranging from 3.67-5.42 μM. It shows high efficacy against CDK1 and 2, with IC50 values of 3-9 nM, and exerts inhibitory effects on a range of human cancer cell types, such as HeLa, HCT-116, SK-OV-3, PC3, DU145, A375, MDA-MB-231, MES-SA, and MES-SA/Dx5, with IC50 values between 112-514 nM, irrespective of p53, retinoblastoma, or P-glycoprotein status. JNJ-7706621 also inhibits CDK3, 4, and 6, with IC50 values of 58-253 nM, and targets Aurora-A and B kinases with IC50 values of 11 and 15 nM, respectively. Furthermore, it inhibits VEGF-R2, FGF-R2, and GSK3β, with IC50 values of 154-254 nM. In HeLa or U937 cells, JNJ-7706621 (0.5-3 μM) delays the exit from the G1 phase, induces cell arrest in the G2-M phase, triggers nuclear replication, activates apoptosis, and reduces colony formation.
  Read more...
• In Vitro:
  JNJ-7706621 (100 or 125 mg/kg) induced tumor regression in mice carrying human melanoma A375 xenografts.
• Cell Research:
  Cell lines: HeLa,HCT-116,A375,SK-OV-3,MDA-MB-231 and PC-3 cells. Concentrations: 1 nM - 10 μM,dissolved in DMSO. Method: Measuring incorporation of 14C-labelled thymidine into newly synthesized DNA within the cells to determine the ability of JNJ-7706621 to inhibit the proliferation of cell growth.Cells are trypsinized and counted and 3-8 ×103 cells are added to each well of a 96-well CytoStar tissue culture treated scintillating microplate in 100 μL complete medium in a volume.Cells are incubated for 24 hours at 37 °C in an atmosphere containing 5% CO2.Next,1 μL JNJ-7706621 is added to the wells of the plate.Cells are incubated for another 24 hours.Methyl 14C-thymidine 56 mCi/mmol is diluted in complete medium and 0.2 μCi/well is added to each well of the CytoStar plate in a volume of 20 μL.The plate is incubated for 24 hours at 37 °C in JNJ-7706621 with 14C-thymidine.The contents of the plate are discarded and the plate is washed twice with 200 μL PBS.200 μL of PBS is added to each well.The top of the plate is sealed with a transparent plate sealer and a white plate backing sealer is applied to the bottom of the plate.The degree of methyl 14C-thymidine incorporation is quantified on a Packard Top Count.
  Read more...
• Animal Research:
  Animal Models: Mouse xenograft model of A375 cellsFormulation & . Dosages: Dissolved in 0.5% methylcellulose containing 0.1% polysorbate 80 in sterile water.100 or 125 mg/kg. Administration: Orally or by intraperitoneal injection
  Read more...

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

inhibit, JNJ 7706621, JNJ7706621, JNJ-7706621, Inhibitor, AuroraKinase, Aurora Kinase, Aurora A, Aurora B, Apoptosis, Cyclin dependent kinase, CDK2/CyclinA, CDK1/CyclinB, CDK, CDK2/CyclinE

Compound Identifiers

PubChem CID

5330790